Fengling Luo

Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis

Fan Chen, Jing Zhou, Fengling Luo et al. · Biochemical and Biophysical Research Communications · 2007 · 215 citations

Medicine, Molecular Biology, Molecular Medicine +12

Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer

Min Liu, Zan Tong, Chuanlin Ding et al. · Journal of Clinical Investigation · 2020 · 183 citations · Full text

Medicine, Immunology, Oncology +17

Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype

Min Liu, Fengling Luo, Chuanlin Ding et al. · The Journal of Immunology · 2015 · 159 citations · Full text

Life Sciences, Immunology, Oncology +17

Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer

Sabrin Albeituni, Chuanlin Ding, Min Liu et al. · The Journal of Immunology · 2016 · 110 citations

Medicine, Immunology, Oncology +17

Ficolin-2 Defends against Virulent Mycobacteria Tuberculosis Infection In Vivo, and Its Insufficiency Is Associated with Infection in Humans

Fengling Luo, Xiaoming Sun, Yubin Wang et al. · PLoS ONE · 2013 · 71 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17